Stock listing
CCCC Stock Price, News, Filings & Events — C4 Therapeutics, Inc.
Selected listing: CCCC · BOATS · USD · US
This page tracks C4 Therapeutics, Inc.'s CCCC:BOATS listing on BOATS in USD for US, including stock price context, company news, filings, investor events, AI research briefs, and market updates for investors following CCCC:BOATS. CCCC:BOATS is the stock-level entry point for investors researching C4 Therapeutics, Inc., while company-level investor report content can remain shared across the same issuer's public listings. 6ix connects this selected listing to available company updates, filings, investor events, replay content, and AI research briefs so stock search leads to the relevant company context without making another exchange listing primary. C4 Therapeutics, Inc. (CCCC) is listed on 6ix with investor news, events, company updates, and market data in one place. Follow the company page to track new releases, upcoming presentations, and the latest information available on 6ix.

- Ticker
- CCCC:BOATS
- Asset type
- Stock
- Market cap
- $431.8M
- Sector
- Health Technology
- Industry
- Biotechnology
- Exchange
- BOATS
- Currency
- USD
C4 Therapeutics, Inc. CCCC:BOATS stock context
This page tracks C4 Therapeutics, Inc.'s CCCC:BOATS listing on BOATS in USD for US, including stock price context, company news, filings, investor events, AI research briefs, and market updates for investors following CCCC:BOATS. CCCC:BOATS is the stock-level entry point for investors researching C4 Therapeutics, Inc., while company-level investor report content can remain shared across the same issuer's public listings. 6ix connects this selected listing to available company updates, filings, investor events, replay content, and AI research briefs so stock search leads to the relevant company context without making another exchange listing primary. C4 Therapeutics, Inc. (CCCC) is listed on 6ix with investor news, events, company updates, and market data in one place. Follow the company page to track new releases, upcoming presentations, and the latest information available on 6ix.
Latest news from C4 Therapeutics, Inc.
C4 Therapeutics to Present New Biomarker Data on the Immunomodulatory Effects of Cemsidomide in Combination with Dexamethasone from its P...
September 3, 2026
C4 Therapeutics Reports Second Quarter 2026 Financial Results and Recent Business Highlights
August 11, 2026
C4 Therapeutics Presents Phase 1 Data at European Hematology Association (EHA) 2026 Congress Highlighting Cemsidomide as a Potential Best...
June 11, 2026
C4 Therapeutics to Participate in Upcoming Conferences
May 20, 2026
C4 Therapeutics Reports First Quarter 2026 Financial Results and Recent Business Highlights
May 12, 2026
Research C4 Therapeutics, Inc.
C4 Therapeutics, Inc. investor report
Review AI stock analysis and investor report context for CCCC:BOATS.
C4 Therapeutics, Inc. company profile
View the public company page for C4 Therapeutics, Inc. on 6ix.
C4 Therapeutics, Inc. news
Read company news and market updates connected to C4 Therapeutics, Inc..
C4 Therapeutics, Inc. investor events
Find investor webinars, events, and replay context for C4 Therapeutics, Inc..